Esperion raises $33 million in series A tranche

Esperion Therapeutics Inc. (Plymouth, Mich.) raised $33 million in a tranche of a series A round led by new investor Longitude Capital. Existing investors Aisling Capital; Alta Partners; Domain Associates; Arboretum Ventures; and Asset Management also participated. Longitude's Patrick Enright will join Esperion's board. Esperion raised $22.8 million in the A round in 2008. ...